Use of dexmedetomidine for icu sedation

Details Use of dexmedetomidine for icu sedation Use of dexmedetomidine for icu sedation

A - Human Necessities

61

K

A61K 31/4174 (2006.01) A61P 25/20 (2006.01)

Patent

CA 2326339

The present invention relates to a method of sedating a patient while in the intensive care unit (ICU). The method comprises administering dexmedetomidine or a pharmaceutically acceptable salt thereof to a patient in need thereof for a sufficient time period. Further, the present invention relates to a method of sedating a patient in the ICU by administering dexmedetomidine or a pharmaceutically acceptable salt thereof, wherein dexmedetomidine is essentially the sole active agent or the sole active agent.

La présente invention concerne un procédé de sédation d'un patient se trouvant dans une unité de soins intensifs. Ce procédé consiste à administrer de la dexmédétomidine ou un de ses sels pharmaceutiquement acceptables à un patient sous traitement pendant une durée suffisante. En outre, la présente invention concerne un procédé de sédation d'un patient dans une unité de soins intensifs par administration de dexmédétomidine ou d'un de ses sels pharmaceutiquement acceptables, la dexmédétomidine étant essentiellement le seul principe actif ou le seul principe actif.

Affiliated with

Also associated with

Rating

Use of dexmedetomidine for icu sedation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of dexmedetomidine for icu sedation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dexmedetomidine for icu sedation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1710147